Associate Sponsors

Co-sponsor

Sales rise 45.41% to Rs 182.02 crore

Net Loss of Panacea Biotec reported to Rs 19.33 crore in the quarter ended September 2020 as against net loss of Rs 75.00 crore during the previous quarter ended September 2019. Sales rose 45.41% to Rs 182.02 crore in the quarter ended September 2020 as against Rs 125.18 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales182.02125.18 45 OPM %20.65-6.53 -PBDT-7.86-46.18 83 PBT-19.24-57.26 66 NP-19.33-75.00 74

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 12 2020 | 10:21 AM IST

Next Story